Thema: INE540L01014
Alkem, INE540L01014
financial-2860753_1920.jpg - Foto: THN
Alkem stock steadies as Mandva FDA inspection ends without Form 483
Alkem stock is in focus after a US FDA inspection ended without a Form 483. Governance actions remain a key investor watchpoint.
ad-hoc-news.de, heute 02:37 Uhr
Alkem, INE540L01014
Alkem appoints two senior managers as Alkem stock nears ...
Alkem added two senior managers on October 12, 2026. Alkem stock stood at INR 4,995.00 on October 19, 2026, 0.40 percent above INR 4,975.05.
ad-hoc-news.de, 20.10.26 04:01 Uhr
Alkem, INE540L01014
Macquarie upgrades Alkem stock to Buy with INR 6,000 target ...
Macquarie set an INR 6,000 target on October 7, 2026 and upgraded Alkem. Alkem stock posted 11.00 percent first-quarter revenue growth.
ad-hoc-news.de, 14.10.26 07:07 Uhr
Alkem, INE540L01014
Alkem stock gains 1.92 percent before October 7 investor ...
Alkem stock rose before its October 7, 2026 meeting with HDFC Mutual Fund. Q1 FY27 revenue grew 10.95 percent, while net profit fell 21.21 percent.
ad-hoc-news.de, 07.10.26 01:00 Uhr
Alkem, INE540L01014
Alkem Laboratories stock slips as guarantee adds risk
Alkem Laboratories stock closed at INR 5,331.50 on September 22, 2026, down 0.61 percent on NSE. June revenue rose 2.35 percent quarter on quarter.
ad-hoc-news.de, 23.09.26 08:19 Uhr
